
501 - 1000 employees
Founded 2014
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
🕒 June 16
Improve your chances of getting an interview by checking your resume score before you apply.

501 - 1000 employees
Founded 2014
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
Biotechnology • Pharmaceuticals • Healthcare Insurance
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
• The LCL is responsible for shaping the program's cross-functional vision, strategic context, and lifecycle plan (LCP) for both current and future business opportunities. • The LCL, in partnership with the Program Manager, will work with leadership & SMEs (subject matter experts) to build out appropriate internal ways of working to enable best practices around development of data driven recommendations, decision making and communication. • As the single point of accountability in a cross-functional team, the LCL ensures timely delivery and manages the associated execution plan and milestones, closely aligning them with the approved LCP. • The LCL oversees integration across Iovance involving multiple stakeholders to ensure optimal program execution in line with program strategy and LCP. • Collaborating with functional team leaders, the LCL fosters alignment across the different sub -teams to ensure execution will achieve team and corporate goals (Commercial Team, Development Team, Regulatory Team etc.) • Serving as a point of triage, the LCL facilitates clear decision-making by incorporating cross-functional input to address high-impact issues. This involves co-creating solutions to complex challenges in real time. • The LCL leads the team in framing program needs and develops a range of options and recommendations for presentation to the Executive Leadership Team (ELT). The LCL ensures transparent communication with senior leadership, highlighting relevant scenarios, assumptions, and risks to inform decision-making and trade-offs. The LCL also represents the enterprise mindset and ensures all relevant functional perspectives have been considered. • The LCL ensures the inclusion of subject matter experts (SMEs) and situational members in discussions, guided by a predefined agenda set with guidance from the Program Manager. • The LCL is accountable to the ELT for program recommendations and frames them within the context of the broader portfolio. • The LCL is accountable for day-to-day management of the program to ensure all established deliverables with high program impact remain on track and in line with program strategy. • The LCL is responsible for ensuring the health of the team, creating a highly functional environment with collaborative ways of working where debate and honest feedback are encouraged • Other responsibilities to consider: Risk identification and mitigation planning; ensuring financial stewardship of approved and recommended projects; clear communication throughout organization of key milestones, deliverables and progress; ensure appropriate resourcing of functions to achieve program goals and vision.
• Bachelor's degree in a scientific discipline; advanced or professional degree highly desirable (e.g., PhD, MD, or MBA). • 15+ years of bio-pharmaceutical industry experience with at least 5 years of relevant work experiences in the biotech/pharmaceutical industry as a Lifecycle Leader or Program Team Leader. • Must demonstrate strong knowledge of the overall drug development process relevant to biotech/ pharmaceutical companies; commercial launch experience and a depth of experience with drug development is required. • Experience working with or on program strategy teams required.
• Iovance is committed to cultivating and offering a diverse and inclusive work environment. • Equal-opportunity employer. • Reasonable accommodations may be made upon request to enable individuals to perform essential functions.
Apply Now🕒 June 16
Associate Director directing brand and experience strategies for university partners at Noodle. Collaborating on marketing and engagement strategies across the full recruitment lifecycle.
🇺🇸 United States – Remote
💵 $75k - $80k / year
💰 $50M Series C on 2021-10
⏰ Full Time
🟠 Senior
👔 Director
🦅 H1B Visa Sponsor
🕒 June 16
Director of Portfolio Asset Management overseeing multifamily loan portfolios at The Community Preservation Corporation. Leading a team and ensuring risk management in affordable housing finance.
🕒 June 16
Associate Director, Client Media Solutions overseeing media activation campaigns. Leading strategy and management for healthcare clients at Real Chemistry.
🕒 June 16
Director overseeing global category strategy for power infrastructure at Vantage Data Centers. Leading sourcing, supplier management, and execution for high-scale energy projects.
🕒 June 16
Director overseeing global category strategy for modular and integrated infrastructure products. Collaborating with teams to align sourcing strategies with product architecture and global deployment standards.